Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
orphenadrine glutamate receptor ionotropic, nmda 1 small molecule NA drugbank , DGIDB Acute onset pain[MeSHID:D059787]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 1.48 approved antagonist
orphenadrine glutamate receptor ionotropic, nmda 2d small molecule NA drugbank , DGIDB Acute onset pain[MeSHID:D059787]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 1.93 approved antagonist
orphenadrine glutamate receptor ionotropic, nmda 3a small molecule NA drugbank , DGIDB Acute onset pain[MeSHID:D059787]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 2.12 approved antagonist
orphenadrine glutamate receptor ionotropic, nmda 3b small molecule NA drugbank , DGIDB Acute onset pain[MeSHID:D059787]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 2.65 approved antagonist
orphenadrine histamine h1 receptor small molecule NA drugbank , DGIDB Acute onset pain[MeSHID:D059787]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 0.41 approved antagonist
orphenadrine sodium channel protein type 10 subunit alpha small molecule NA drugbank Acute onset pain[MeSHID:D059787]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 NA approved inhibitor
orphenadrine sodium-dependent noradrenaline transporter small molecule NA drugbank Acute onset pain[MeSHID:D059787]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 NA approved inhibitor
click here to return to the previous page